Bente Lund

20002019
Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 2000 2019

  • 21 Tidsskriftartikel
  • 13 Konferenceabstrakt i tidsskrift
  • 2 Poster
  • 1 Konferenceartikel i tidsskrift
2019

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

PRIMA/ENGOT-OV26/GOG-3012 Investigators, González-Martín, A., Pothuri, B., Vergote, I., DePont Christensen, R., Graybill, W., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., Baumann, K., Jardon, K., Redondo, A., Moore, R. G., Vulsteke, C., O'Cearbhaill, R. E., Lund, B., Backes, F., Barretina-Ginesta, P. & 11 flere, Haggerty, A. F., Rubio-Pérez, M. J., Shahin, M. S., Mangili, G., Bradley, W. H., Bruchim, I., Sun, K., Malinowska, I. A., Li, Y., Gupta, D. & Monk, B. J., 28 sep. 2019, I : The New England Journal of Medicine.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Ovarian Neoplasms
Disease-Free Survival
Platinum
Homologous Recombination
Placebos

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

Del Campo, J. M., Matulonis, U. A., Malander, S., Provencher, D., Mahner, S., Follana, P., Waters, J., Berek, J. S., Woie, K., Oza, A. M., Canzler, U., Gil-Martin, M., Lesoin, A., Monk, B. J., Lund, B., Gilbert, L., Wenham, R. M., Benigno, B., Arora, S., Hazard, S. J. & 1 flere, Mirza, M. R., 7 jun. 2019, I : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 10 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Platinum
Ovarian Neoplasms
Drug Therapy
Germ-Line Mutation
Therapeutics
1 Citation (Scopus)

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

Mirza, M. R., Åvall Lundqvist, E., Birrer, M. J., dePont Christensen, R., Nyvang, G-B., Malander, S., Anttila, M., Werner, T. L., Lund, B., Lindahl, G., Hietanen, S., Peen, U., Dimoula, M., Roed, H., Ør Knudsen, A., Staff, S., Krog Vistisen, A., Bjørge, L., Mäenpää, J. U., AVANOVA investigators & 1 flere, Lund, B., okt. 2019, I : The Lancet. Oncology. 20, 10, s. 1409-1419 11 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Platinum
Ovarian Neoplasms
Disease-Free Survival
Drug Therapy
Therapeutics
2018

A time without symptoms or toxicity analysis of niraparib compared with routine surveillance in the maintenance treatment of patients with recurrent ovarian cancer

Mirza, M. R., Walder, L., Monk, B. J., Tinker, A. V., Mahner, S., Gil-Martin, M., Kalbacher, E., Waters, J., Wenham, R. M., Malander, S., Gilbert, L., Sehouli, J., Casado Herraez, A., Hardy-Bessard, A., Williams, S. J., Rimel, B. J., Lund, B., Levy, T., Guy, H. & Matulonis, U. A., okt. 2018, I : Value in Health. 21, Suppl. 3, s. S16 PCN7.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

A time without symptoms or toxicity analysis of niraparib compared with routine surveillance in the maintenance treatment of patients with recurrent ovarian cancer

Mirza, M. R., Walder, L., Monk, B. J., Tinker, A. V., Mahner, S., Gil-Martin, M., Kalbacher, E., Waters, J., Wenham, R. M., Malander, S., Gilbert, L., Sehouli, J., Casado Herraez, A., Hardy-Bessard, AC., Williams, SJ., Rimel, BJ., Lund, B., Levy, T., Guy, H. & Matulonis, U. A., 2018. 1 s.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

16 Citationer (Scopus)

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

Oza, A. M., Matulonis, U. A., Malander, S., Hudgens, S., Sehouli, J., Del Campo, J. M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Vázquez, I. P., D'Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S. & Mirza, M. R., 2018, I : The Lancet. Oncology. 19, 8, s. 1117-1125 9 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Ovarian Neoplasms
Randomized Controlled Trials
Placebos
Quality of Life
Platinum
2017

Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA trial

Oza, A. M., Matulonis, U. A., Malander, S., Sehouli, J., del Campo, J. M., Berthon-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Palacio Vázquez, I., D’hondt, V., Benigno, B., Provencher, D. M., Buscema, J., Hudgens, S., Agarwal, S. & Mirza, M. R., 2017, I : Annals of Oncology. 28, Suppl. 5, s. 330 1 s., 930O.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Åben adgang
2016

An Open-Labelled, Randomized Phase II Study in Patients with Recurrent Glioblastoma Multiforme Comparing Progression Free Survival of Alecsat (Autologous Lymphoid Effector Cells Specific Against Tumour-Cells) Versus Bevacizumab/irinotecan

Haslund, C., Muhic, A., Lukacova, S., Lund, B., Lassen-Ramshad, Y., Meyer, M., Roland, M. & Poulsen, H. S., 1 okt. 2016, I : Neuro-Oncology. 18, s. iv6 1 s.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Circulating tumor cell number predicts time to progression (TTP) in patients with heavily pretreated gynecological cancers treated with selinexor (SEL)

Crochiere, M., Vergote, I. B., Lund, B., Havsteen, H., Ujmajuridze, Z., Van Nieuwenhuysen, E., Haslund, C., Juhler-Nottrup, T., Mau-Sorensen, M., Berteloot, P., Kranich, A. L., Meade, J., Wright, G., Shacham, E., Rashal, T., Saint-Martin, J-R., Shacham, S., Kauffman, M., Mirza, M. R. & Landesman, Y., 2016, I : Annals of Oncology. 27, Suppl. 6, 886P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

9 Citationer (Scopus)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer

Dahl Steffensen, K., Waldstrøm, M., Brandslund, I., Lund, B., Mejer Sørensen, S., Petzold, M. & Jakobsen, A., 2016, I : Oncology Letters. 11, 6, s. 3967-3974 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
1 Citation (Scopus)

Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

Vergote, I., Lund, B., Havsteen, H., Ujmajuridze, Z., Van Nieuwenhuysen, E., Haslund, C., Juhler-Nottrup, T., Neven, P., Mau-Sorensen, M., Berteloot, P., Kranich, A. L., Rashal, T., Meade, J., Landesman, Y., Saint-Martin, J-R., Wright, G., Crochiere, M., Shacham, S., Kauffman, M. & Mirza, M. R., 2016, I : Annals of Oncology. 27, Suppl. 6, 8540O.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

86 Citationer (Scopus)

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

du Bois, A., Kristensen, G., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G. & 8 flere, Meier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. O., Merger, M., Harter, P. & AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium, jan. 2016, I : Lancet Oncology. 17, 1, s. 78-89 12 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Ovarian Neoplasms
Placebos
Drug Therapy
Carboplatin
Paclitaxel
2015

Preliminary phase II results of selinexor, an oral selective inhibitor of nuclear export in patients with heavily pretreated gynecological cancers

Vergote, I., Lund, B., Havsteen, H., Ujmajuridze, Z., Leunen, K., Haslund, C. A., Juhler-Nøttrup, T., Roed, H., Rashal, T., Kranich, A. L., Landesman, Y., Saint-Martin, J-R., Carlson, R., Shacham, S., Kauffman, M. & Mirza, M. R., 2015, I : Journal of Clinical Oncology. 33, 15 Suppl., TPS5565.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Cell Nucleus Active Transport
Neoplasms
Colorectal Neoplasms
KPT-330
Survival
229 Citationer (Scopus)
70 Downloads (Pure)

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Oza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T-W., Rustin, G., Joly, F., Mirza, M. R., Plante, M., Quinn, M. S., Poveda, A., Jayson, G. C., Stark, D., Swart, A. M. & 5 flere, Farrelly, L., Kaplan, R., Parmar, M. K. B., Perren, T. J. & ICON7 trial investigators, aug. 2015, I : Lancet Oncology. 16, 8, s. 928-936 9 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Ovarian Neoplasms
Drug Therapy
Survival
Disease-Free Survival
Survival Rate
2014
5 Citationer (Scopus)

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Wang, Y., Herrstedt, J., Havsteen, H., Christensen, R. D., Mirza, M. R., Lund, B., Maenpaa, J. & Kristensen, G., 2014, I : B M C Cancer. 2014, 14, 937.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang

Disease relapse in ovarian cancer patients detected by HE4 and CA125

Steffensen, K. D., Waldstrøm, M., Brandslund, I., Lund, B., Sørensen, S. M., Petzold, M. & Jakobsen, A., 2014, I : International Journal of Gynecological Cancer. 29, 9, 4 suppl., s. 189

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

KCP-330-005/SIGN: A phase II, open-label study of efficacy and safety of the selective inhibitor of nuclear export (SINE) KPT-330 (SELINEXOR) in patients with advanced gynaecologic malignancies

Vergote, I., Lund, B., Ujmajuridze, Z., Havsteen, H., Rashal, T., McCartney, J., Kauffman, M., Shacham, S. & Mirza, M. R., 2014, I : International Journal of Gynecological Cancer. 29, 9, 4 suppl., s. 1182

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Vellykket behandling af lokal avanceret, småcellet, neuroendokrint cervixkarcinom

Rasmussen, L. B., Lindegaard, J. C., Lund, B., Grove, A. & Fokdal, L. U., 2014, I : Ugeskrift for Laeger. 176, 2 s., V06140374.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

2013

Clinical impact of 18F-FDG PET/contrast enhanced (ce)CT in women presenting with adnexal masses

Frost, M., Fisker, R. V., Søgaard-Andersen, E., Grove, A., Lund, B. & Iyer, V. V., 2013.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

17 Citationer (Scopus)

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: the PaLiDo study, a phase II nonrandomized multicenter study

Steffensen, K. D., Waldstrøm, M., Pallisgård, N., Lund, B., Bergfeldt, K., Wihl, J., Keldsen, N., Marth, C., Vergote, I. & Jakobsen, A., 1 jan. 2013, I : International Journal of Gynecological Cancer. 23, 1, s. 73-80 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Platinum
Multicenter Studies
Ovarian Neoplasms
Confidence Intervals
Skin
2 Citationer (Scopus)

Primært malignt melanom i vagina

Kahr, H. S., Mejlgaard, E. & Lund, B., 14 jan. 2013, I : Ugeskrift for Laeger. 175, 3, s. 133-4 2 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vagina
Melanoma
Pelvic Exenteration
Urethra
Recurrence
2012
27 Citationer (Scopus)

Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial

Brundage, M., Gropp, M., Mefti, F., Mann, M. K., Lund, B., Gebski, V., Wolfram, G., Reed, N., Pignata, S., Ferrero, A., Brown, J. C., Eisenhauer, E. & Pujade-Lauraine, E., aug. 2012, I : Annals of Oncology. 23, 8, s. 2020-7 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Carboplatin
Platinum
Ovarian Neoplasms
Quality of Life
Paclitaxel

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study.

Steffensen, K. D., Waldstrom, M., Pallisgård, N., Lund, B., Bergfeldt, K., Wihl, J., Keldsen, N., Marth, C., Vergote, I. B. & Jakobsen, A. K. M., 20 maj 2012, I : Journal of Clinical Oncology. 30, 15

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

2011
1115 Citationer (Scopus)

A phase 3 trial of bevacizumab in ovarian cancer

Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., du Bois, A., Sehouli, J., Kimmig, R., Stähle, A., Collinson, F., Essapen, S., Gourley, C., Lortholary, A., Selle, F., Mirza, M. R. & 7 flere, Leminen, A., Plante, M., Stark, D., Qian, W., Parmar, M. K. B., Oza, A. M. & ICON7 Investigators, 29 dec. 2011, I : The New England Journal of Medicine. 365, 26, s. 2484-96 13 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Ovarian Neoplasms
Disease-Free Survival
Survival
Disease Progression
Bevacizumab
27 Citationer (Scopus)

Improved Classification of Epithelial Ovarian Cancer: Results of 3 Danish Cohorts

Steffensen, K. D., Waldstrom, M., Grove, A., Lund, B., Pallisgard, N. & Jakobsen, A., 16 sep. 2011, I : International Journal of Gynecological Cancer. 21, s. 1592-1600 9 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Mutation
Neoplasms
Survival
Codon
Ovarian epithelial cancer
10 Citationer (Scopus)

Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP)

Jensen, I., Carl, J., Lund, B., Larsen, E. H. & Nielsen, J. N., 2011, I : Medical Dosimetry. 36, s. 130-7 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Prostatic Neoplasms
Radiotherapy
Conformal Radiotherapy
Neoplasms
Therapeutics
2010
11 Citationer (Scopus)

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Mirza, M. R., Lund, B., Lindegaard, J. C., Keldsen, N., Mellemgaard, A., Christensen, R. D. & Bertelsen, K., 1 okt. 2010, I : Gynecologic Oncology. 119, s. 26-31 6 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

gemcitabine
Combination Drug Therapy
Drug Therapy
Therapeutics
Ovarian epithelial cancer

Health-related quality of life (HRQL) and progression-free survival (PFS) in patients with recurrent ovarian cancer: Results from the CALYPSO trial

Brundage, M., Gropp, M., Mefti, F., Mann, M. K., Lund, B., Gebeski, V., Wolfram, G., Reed, N., Pignata, S. & Ferrero, A., 20 maj 2010, I : Journal of Clinical Oncology. 28, 15, 5044.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Panitumumab and pegylated liposomal doxorubicin to platinum-resistant epithelial ovarian cancer with KRAS wild-type: An ongoing, nonrandomized, multicenter, phase II trial.

Steffensen, K. D., Waldstrøm, M., Lund, B., Bergfeldt, K., Keldsen, N., Marth, C., Vergote, I. B. & Jakobsen, A. K., 2010, I : Journal of Clinical Oncology. 28, 15suppl, TPS254.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Platinum
Ovarian Neoplasms
Combination Drug Therapy
Epidermal Growth Factor Receptor
Neoplasms
2006
3 Citationer (Scopus)
401 Downloads (Pure)

Automated detection of a prostate Ni-Ti stent in electronic portal images.

Carl, J. H., Nielsen, H., Nielsen, J., Lund, B. & Larsen, E. H., 2006, I : Medical Physics. 33, 12, s. 4600-4605 6 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Stents
Prostate
Radiotherapy
Uncertainty
titanium nickelide
16 Citationer (Scopus)

Feasibility study using a Ni-Ti stent and electronic portal imaging to localize the prostate during radiotherapy.

Carl, J. H., Lund, B., Larsen, E. H. & Nielsen, J., 2006, I : Radiotherapy and Oncology. 78, s. 199-206

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Pegylated liposomal doxorubicin (PLD) and gemcitabine (GEM) in combination in the salvage treatment of epithelial ovarian cancer (OC)—a Danish Gynaecologic Cancer Group (DGC) study

Mirza, M. R., Lund, B., Bertelsen, K., Lindegaard, J., Keldsen, N., Mellemgaard, A. & Depont, R., 20 jun. 2006, I : Journal of Clinical Oncology. 24, 18_suppl, 1 s., 5094.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

2005
5 Citationer (Scopus)

Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) comparing TCG with standard TC

Bois, A. D., Sehouli, J., Lund, B., Joly, E., Huober, J., Jensen, TS., Levy, E., Heilmann, V., Boman, K., Hardy-Bessard, AC., Burges, A., Maenpaa, J., Pujade-Lauraine, E., Pfisterer, J., Gropp, M., Staehle, A., Wimberger, P., Jackisch, C., Schmalfeldt, B., Belau, A. & 5 flere, Loibl, S., Wollschlaeger, K., Canzler, U., Rochon, J. & GINE, GCIG. I. AGO-OVAR. NSGO., 1 nov. 2005, I : International Journal of Gynecological Cancer. 15, Suppl. 3, s. 224-225 2 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

26 Citationer (Scopus)

The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark

Andersen, E. S., Knudsen, A., Svarrer, T., Lund, B., Nielsen, K., Grove, A. & Tetsche, M. S., 2005, I : Gynecologic Oncology. 99, 3, s. 552-556 5 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

2001
11 Citationer (Scopus)

Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer

Underhill, CR., Parnis, FX., Highley, MS., Ahern, J., Harper, PG., Hansen, H., Lund, B., Dombernowsky, P., Hirsch, F., Hansen, M., Carmichael, J. & Williams, H. C., 1 sep. 2001, I : Anti-Cancer Drugs. 12, 8, s. 647-652 6 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

2000
364 Citationer (Scopus)

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer

Neijt, JP., Engelholm, SA., Tuxen, MK., Sorensen, PG., Hansen, M., Sessa, C., Swart, CAM. D., Hirsch, FR., Lund, B. & Houwelingen, HC. V., 1 sep. 2000, I : Journal of Clinical Oncology. 18, 17, s. 3084-3092 9 s.

Publikation: Bidrag til tidsskriftKonferenceartikel i tidsskriftForskningpeer review